Article
Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.
BMC cancer - 6 Nov 2008
Wedrén Sara, Lovmar Lovisa, Humphreys Keith, Magnusson Cecilia, Melhus Håkan, Syvänen Ann-Christine, Kindmark Andreas, Landegren Ulf, Fermér Maria Lagerström, Stiger Fredrik, Persson Ingemar, Baron John A, Weiderpass Elisabete
Abstract excerpt
BACKGROUND: Estrogen is an established endometrial carcinogen. One of the most important mediators of estrogenic action is the estrogen receptor alpha. We have investigated whether polymorphic variation in the estrogen receptor alpha gene (ESR1) is associated with endometrial cancer risk. METHODS: In 702 cases with invasive endometrial cancer and 1563 controls, we genotyped five markers in ESR1 and used logistic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
